Saturday, 24 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDrug

Hainan Haiyao Concludes Phase I Clinical Study for PaiEnJiaBin, a Novel KCNQ Agonist

November 22, 2024
CompanyDeals

Sino Medical Sciences Technology to Acquire Majority Stake in US Endovascular Device Firm eLum

November 22, 2024
CompanyMedical Device

Acotec Scientific Holdings Receives Marketing Approvals for Vericor-14 Microcatheter in Japan and Thailand

November 22, 2024
CompanyDrug

Brii Biosciences Announces Positive Interim Data for BRII-179 Vaccine in Chronic Hepatitis B

November 22, 2024
CompanyDrug

MSD’s Gardasil 9 HPV Vaccine Demonstrates 10-Year Efficacy in Adolescents

December 10, 2024
CompanyDeals

Sinovac Biotech Directors Reject Alternative Liquidity’s Lowball Tender Offer

November 22, 2024
CompanyDeals

Abbott to Acquire Insulin Management Firm Bigfoot Biomedical

November 22, 2024
Policy / Regulatory

Taizhou Port Designated as Drug Import Port by NMPA and General Administration of Customs

November 22, 2024
Company

Sandoz Reports H1 2023 Financials with 8% YOY Growth, Separation from Novartis Looms

November 22, 2024
Policy / Regulatory

Li Li Appointed as New Director of NMPA

November 22, 2024
Policy / Regulatory

NHSA Mandates National Standards for Medical Consumables in Basic Medical Insurance

November 22, 2024
CompanyDeals

Bristol-Myers Squibb Acquires Rights to Zenas BioPharma’s Obexelimab for Autoimmune Diseases

November 22, 2024
1 2 … 19 20 21 22 23 24 25
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up